Radiofrequency ablation for treatment of renal tumors: Technological principles and outcomes

Expert Review of Medical Devices

Volumn 8, Issue 6, 2011, Pages 695-707

  Salas, Nelson ^a,b   Castle, Scott M ^a   Leveillee, Raymond J ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b University of Miami   (United States)

Author keywords

ablation; conduction; current; heat; kidney; radiofrequency; tumor

Indexed keywords

BLOOD FLOW; CONVECTIVE HEAT; ELECTRICAL PROPERTY; END POINTS; FUTURE TRENDS; HEAT; KIDNEY; MINIMALLY INVASIVE; NEEDLE PROBES; NON-INVASIVE IMAGING; PHYSICAL LIMITATIONS; RADIO FREQUENCIES; RADIOFREQUENCY ABLATION; RENAL TUMORS; TISSUE IMPEDANCES; TREATMENT MODALITY;

CARBONIZATION; ELECTRIC PROPERTIES; NEEDLES; TUMORS;

ABLATION;

ALGORITHM; DEPOLARIZATION; ELECTRIC POTENTIAL; ELECTROMAGNETIC FIELD; FOLLOW UP; HEAT LOSS; HEAT TRANSFER; HUMAN; IMPEDANCE; KIDNEY BLOOD FLOW; KIDNEY TUMOR; MECHANICAL PROBE; MEDLINE; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; RENOGRAPHY; REVIEW; RISK REDUCTION; STEADY STATE; SURGICAL RISK; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THERMODYNAMICS; THERMOMETRY; TREATMENT OUTCOME;

CATHETER ABLATION; HUMANS; KIDNEY NEOPLASMS; TREATMENT OUTCOME;

EID: 80155214337     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.11.51     Document Type: Review

References (70)

1. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 51(2), 203-205 (1998).
2. Kutikov A, Kunkle DA, Uzzo RG. Focal therapy for kidney cancer: a systemic review. Curr. Opin. Urol. 19, 148-153 (2009).
3. Gill IS, Kavoussi LR, Lane BR et al. Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors. J. Urol. 178, 41-46 (2007).
4. Lane BR, Gill IS. 5-year outcomes of laparoscopic partial nephrectomy. J. Urol. 177, 70-74 (2007).
5. Campbell SC, Novick AC, Belldegrun A et al. Guideline for management of the clinical T1 renal mass. J. Urol. 182(4), 1271-1279 (2009).
6. Bird VG, Carey RI, Ayyathurai R, Bird VY. management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy. J. Endourol. 23(1), 81-88 (2009).
7. Carey RI, Leveillee RJ. First prize: direct real-time temperature monitoring for laparoscopic and CT-guided radiofrequency ablation of renal tumors between 3 and 5 cm. J. Endourol. 21(8), 807-813 (2007).
8. Wingo MS, Leveillee RJ. Central and deep renal tumors can be effectively ablated: radiofrequency ablation outcomes with fiberoptic peripheral temperature monitoring. J. Endourol. 22(6), 1-7 (2008).
9. Stern JM, Svatek R, Park S et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumors. BJU Int. 100, 287-290 (2007).
10. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J. Urol. 179, 75-80 (2008).
11. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351(13), 1296-1305 (2004).
12. Leveillee RJ, Hoey MF. Radiofrequency interstitial tissue ablation: wet electrode. J. Endourol. 17(8), 563-577 (2003).
13. Hoffmann E, Haberl R, Pulter R, Gokel M, Steinbeck G. Biophysical parameters of radiofrequency catheter ablation. Int. J. Cardiol. 37, 213-222 (1992).
14. Thomas LC. Introduction. In:Heat Transfer - Professional Version . Thomas LC (Ed.). Capstone Publishing Corporation, Tulsa, OK, USA, 1-28 (1999).
15. Nath S, DiMarco JP, Haines DE. Basic aspects of radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol 5(10), 863-876 (1994).
16. Orr C-S, Eberhart RC. Overview of bioheat transfer. In:Optical-Thermal Response of Laser-Irradiated Tissue . Welch AJ, van Gemert MJC (Eds). Plenum Press, New York, NY, USA, 367-384 (1995).
17. Salas N, Manns F, Milne PJ et al. Thermal analysis of laser interstitial thermotherapy in ex vivo fibro-fatty tissue using exponential functions. Phys. Med. Biol. 49, 1609-1624 (2004).
18. Matsumoto ED, Johnson DB, Ogan K et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 65, 877-881 (2005).
19. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J. Endourol. 20(8), 569-573 (2006).
20. Raman JD, Raj GV, Lucas SM et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 105, 496-500 (2009).
21. Levinson AW, Su LM, Agarwal D et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J. Urol. 180, 499-504 (2008).
22. Ahrar k, Matin S, Wood CG et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J. Vasc. Interv. Radiol. 16, 679-688 (2005).
23. Arzola J, Baughman SM, Hernandez J, Bishoff JT. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology 68(5), 983-987 (2006).
24. Gupta A, Raman JD, Leveillee RJ et al. General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results. J. Endourol. 23(7), 1099-1105 (2009).
25. Hoffmann RT, Jakobs TF, Kubisch CH et al. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results. Eur. J. Radiol. 73, 652-656 (2010).
26. Mahnken AH, Rohde D, Brkovic D, Gunther RW, Tacke JA. Percutaneous radiofrequency ablation of renal cell carcinoma: preliminary results. Acta Radiol. 46, 208-214 (2005).
27. Turna B, Kaouk JH, Frota R et al. Minimally invasive nephron sparing management for renal tumors in solitary kidneys. J. Urol. 182, 2150-2157 (2009).
28. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am. J. Roentgenol. 189(2), 429-436 (2007).
29. Lewin JS, Nour SG, Connell CF et al. Phase II clinical trial of interactive MR imaging-guided interstitial radiofrequency thermal ablation of primary kidney tumors: initial experience. Radiology 232, 835-845 (2004).
30. Laeseke PF, Sampson LA, Brace CL W et al. Unintended thermal injuries from radiofrequency ablation: protection with 5% dextrose in water. AJR Am. J. Roentgenol. 186, S249-S254 (2006).
31. Pearce J, Thomsen S. Rate process analysis of thermal damage. In:Optical-Thermal Response of Laser-Irradiated Tissue . Welch AJ, van Gemert MJC (Eds). Plenum Press, New York, NY, USA, 561-606 (1995).
32. Niemz MH. Interaction mechanisms. In:Laser-Tissue Interactions . Niemz MH (Ed.). Springer-Verlag, Heidelberg, Germany, 45-147 (1996).
33. Crowley JD, Shelton J, Iverson AJ, Burton MP, Dalrymple NC, Bishoff JT. Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology 57(5), 976-980 (2001).
34. Hsu TH, Fidler ME, Gill IS. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology 56(5), 872-875 (2000).
35. Salagierski M, Salagierski MS, Salagierska- Barwinska A. Radiofrequency ablation in kidney tumour management: a method of real-time monitoring. Scand. J. Urol. Nephrol. 44, 84-90 (2010).
36. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J. Urol. 174(1), 61-63 (2005).
37. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 116(13), 3135-3142 (2010).
38. Ferakis N, Bouropoulos C, Granitsas T, Mylona S, Poulias I. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors. J. Endourol. 24(12), 1909-1913 (2010).
39. Takaki H, Yamakado K, Soga N et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J. Radiol. 28(6), 460-468 (2010).
40. Ji C, Li X, Zhang S et al. Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 77(4), 798-802 (2011).
41. Salas N, Ramanathan R, Dummett S, Leveillee RJ. Results of radiofrequency kidney tumor ablation: renal function preservation and oncologic efficacy. World J. Urol. 28, 583-591 (2010).
42. Cutress ML, Ratan HL, Williams ST, OBrien MF. Update on the management of T1 renal cortical tumours. BJU Int. 106(8), 1130-1136 (2010).
43. Mulier S, Ni Y, Frich L et al. Experimental and clinical radiofrequency ablation: proposal for standardized description of coagulation size and geometry. Ann. Surg. Oncol. 14(4), 1381-1396 (2007).
44. Ahmed M, Liu Z, Humphries S, Goldberg SN. Computer modeling of the combined effects of perfusion, electrical conductivity, and thermal conductivity on tissue heating patterns in radiofrequency tumor ablation. Int. J. Hyperthermia 24(7), 577-588 (2008).
45. Liu Z, Ahmed M, Gervais D, Humphries S, Goldberg SN. Computer modeling of factors that affect the minimum safety distance required for radiofrequency ablation near adjacent nontarget structures. J. Vasc. Interv. Radiol. 19(7), 1079-1086 (2008).
46. Chinn SB, Fred T. Lee J, Kennedy GD et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am. J. Roentgenol. 176, 789-795 (2001).
47. Lobik L, Leveillee RJ, Hoey MF. Geometry and temperature distribution during radiofrequency tissue ablation: an experimental ex vivo model. J. Endourol. 19(2), 242-247 (2005).
48. Clark PE, Woodruff RD, Zagoria RJ, Hall MC. Microwave ablation of renal parenchymal tumors before nephrectomy: Phase I study. AJR Am. J. Roentgenol. 188(5), 1212-1214 (2007).
49. Hope WW, Schmelzer TM, Newcomb WL et al. Guidelines for power and time variables for microwave ablation in an in vivo porcine kidney. J. Surg. Res. 153(2), 263-267 (2008).
50. Laeseke PF, Lee FT, Sampson LA, van der Weide DW, Brace CL. Microwave ablation versus radiofrequency ablation in the kidney: high-power triaxial antennas create larger ablation zones than similarly sized internally cooled electrodes. J. Vasc. Interv. Radiol. 20(9), 1224-1229 (2009).
51. Liang P, Wang Y, Zhang D, Yu X, Gao Y, Ni X. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience. J. Urol. 180, 844-848 (2008).
52. Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2), 426-433 (2010).
53. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality - clinical implications. technology in cancer research and treatment. Tecnol. Cancer Res. Treat. 6(1), 37-48 (2007).
54. Rubinsky J, Onik G, Mikus P, Rubinsky B. Optimal parameters for the destruction of prostate cancer using irreversible electroporation. J. Urol. 180, 2668-2674 (2008).
55. Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr. Opin. Urol. 19, 188-191 (2009).
56. Margreiter M, Marberger M. Focal therapy and imaging in prostate and kidney cancer: high-intensity focused ultrasound ablation of small renal tumors. J. Endourol. 24(5), 745-748 (2010).
57. Orvieto MA, Zorn KC, Lyon MB et al. High intensity focused ultrasound renal tissue ablation: a laparoscopic porcine model. J. Urol. 181, 861-866 (2009).
58. Terraz S, Cernicanu A, Lepetit-Coiffe M et al. Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring. Eur. Radiol. 20(4), 886-897 (2009).
59. Clasen S, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J. Magn. Reson. Imaging 27, 421-433 (2008).
60. Gustafson DE, Nadadur D, Dalmadge GW, Nields M. Mapping and monitoring of ablative thermal therapy for improved results. In:SPIE Photonics West BIOS, Thermal Treatment of Tissue: Energy Delivery and Assessment IV . Ryan TP (Ed.). SPIE, Bellingham, WA, USA, 1-13 (2007).
61. Daniels MJ, Varghese T. Dynamic frame selection for in vivo ultrasound temperature estimation during radiofrequency ablation. Phys. Med. Biol. 55, 4735-4753 (2010).
62. Dyche D, Burks F, Seifman B, Kernen K, Hafron J. Cone beam computed tomography: an assessment of renal image quality and applicability for percutaneous renal cryotherapy in a swine model. Urology 77(2), 497-501 (2010).
63. Huber J, Wegner I, Meinzer HP et al. Navigated renal access using electromagnetic tracking: an initial experience. Surg. Endosc. 25(4), 1307-1312 (2010).
64. Santos RS, Gupta A, Ebright MI et al. Electromagnetic navigation to aid radiofrequency ablation and biopsy of lung tumors. Ann. Thorac. Surg. 89, 265-268 (2010).
65. Sommer CM, Kortes N, Zelzer S et al. Renal artery embolization combined with radiofrequency ablation in a porcine kidney model: effect of small and narrowly calibrated microparticles as embolization material on coagulation diameter, volume, and shape. Cardiovasc. Intervent. Radiol. 34(1), 156-165 (2010).
66. Pedro RN, Thekke-Adiyat T, Goel R et al. Use of tumor necrosis factor-a-coated gold nanoparticles to enhance radiofrequency ablation in a translational model of renal tumors. Urology 76, 494-498 (2010).
67. Wu SD, Viprakasit DP, Cashy J, Smith ND, Perry KT, Nadler RB. Radiofrequency ablation-assisted robotic laparoscopic partial nephrectomy without renal hilar vessel clamping versus laparoscopic partial nephrectomy: a comparison of perioperative outcomes. J. Endourol. 24(3), 385-391 (2010).
68. Prevoo W, van den Bosch MA, Horenblas S. Radiofrequency ablation for treatment of sporadic angiomyolipoma. Urology 72(1), 188-191 (2008).
69. Sooriakumaran P, Gibbs P, Coughlin G et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 105(1), 101-106 (2009).
70. StarBurst MRI RFA Device www.angiodynamics.com/products/starburst-mri